Genetic Variation in the Glucocorticoid Pathway Involved in Interindividual Differences in the Glucocorticoid Treatment
The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs) are widely used for treating asthma, rheumatoid arthritis, nephrotic syndrome, acute lymphoblastic leukemia and other autoimmune diseases. However, in a subgroup of patients, failure to respond to GCs is known as GC resistance or GC insensitivity. This represents an important barrier to effective treatment and a clinical problem requiring an urgent solution. Genetic variation in the GC pathway is a significant factor in interindividual differences in GC treatment. This article reviews the pharmacogenetics of GCs in diverse diseases based on the GC pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying mechanisms of action can be different, ranging from pharmacokinetic and pharmacodynamic properties of the used drugs to genetic predisposition [85].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [85]
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
Self-citationSteroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,179
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
Research works printed but not linked: 4
- 10.1210/jcem.87.4.8379 · doi:10.1210/jcem.87.4.8379 · Paper page
- 10.1210/jcem.87.6.8520 · doi:10.1210/jcem.87.6.8520 · Paper page
- 10.1016/s0140-6736(04)15650-x · DOI · Paper page
- 10.3109/s10165-004-0354-x · doi:10.3109/s10165-004-0354-x
Cited by
Stress and Obesity: Are There More Susceptible Individuals?
van der Valk, E. S., Savas, M., & van Rossum, E. F. C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0306-y · Cited by 402
Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis
Paragliola, R. M., Papi, G., Pontecorvi, A., & Corsello, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102201 · Cited by 181
“The underlying mechanisms of action can be different, ranging from pharmacokinetic and pharmacodynamic properties of the used drugs to genetic predisposition [85].”
BackgroundChronopharmacology of glucocorticoids
Scherholz, M. L., Schlesinger, N., & Androulakis, I. P. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.004 · Cited by 144
Autry, R. J., Paugh, S. W., Carter, R., Shi, L., Liu, J., Ferguson, D. C., Lau, C. E., Bonten, E. J., Yang, W., McCorkle, J. R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0037-3 · Cited by 85
Self-citationDisease-drug and drug-drug interaction in COVID-19: Risk and assessment
Kumar, D., & Trivedi, N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111642 · Cited by 84
“have been associated with corticosteroid response across multiple disease condition [189].”
Metadata
- Authors
- Song, Q.-Q., Xie, W.-Y., Tang, Y.-J., Zhang, J., & Liu, J.
- Affiliations
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha410008, Hunan, P.R. China
- Central South University (CN)
- Venue
- Pharmacogenomics
- Publisher
- Informa UK Limited
- Published
- 2017-01-23
- Volume
- 18
- Issue
- 3
- Pages
- 293-316
- ISSN
- 1462-2416 (ISSN-L)
- 1744-8042
- OpenAlex
- W2583071148
- Cited by
- 40
- References
- 170
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 10 · 2019: 4 · 2018: 2 · 2017: 3
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacogenomics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation (81070902, 30600774)
- China Postdoctoral Science Foundation (201104515, 2012M510138)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- glucocorticoids, glucocorticoid resistance, pharmacogenetics, genetic variation, glucocorticoid pathway, interindividual variability, glucocorticoid treatment response, autoimmune disease
- MeSH terms
- Autoimmune Diseases, Glucocorticoids, Humans, Genetic Variation, Signal Transduction, Treatment Outcome, Polymorphism, Single Nucleotide, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.